News Releases
Fourth Quarter Revenues Up 9.4%: Full Year Revenues Up 12.8%
Adjusted Free Cash Flow Increased 12.0% to
Key fourth quarter and fiscal year highlights include:
-
Reported revenue increased 9.4% to
$207.9 million and 12.8% to$806.2 million in Q4 and FY2016, respectively. - Organic sales grew 5.0% in Q4 and 2.8% in FY2016, on a constant currency basis.
-
Adjusted net income increased 12.7% to
$27.9 million , or$0.52 per diluted share, in Q4. -
FY16 adjusted net income increased 17.8% to
$115.5 million , or$2.17 per diluted share. -
Adjusted free cash flow increased 12.0% to
$183.4 million in FY2016.
Fiscal Fourth Quarter Ended
Reported revenues in the fiscal fourth quarter of 2016 increased 9.4% to
Reported net income totaled
Fiscal Year Ended
Reported revenues for the fiscal year ended
Reported net income for fiscal year 2016 totaled
Adjusted Free Cash Flow and Balance Sheet
Adjusted free cash flow totaled
Segment Review
Household Cleaning: Reported revenues totaled
Commentary and Outlook for FY2017
“Our strong overall performance in the fourth quarter enabled us to
exceed our previous outlook for the quarter and full fiscal year,” said
“We completed the acquisition of DenTek in
Mr. Lombardi continued, “In fiscal 2017, we expect continued organic
growth in our existing business and incremental revenues from the
acquisition of DenTek. We anticipate full fiscal year 2017 revenue
growth in the range of 6.0%-8.0% including the impact of foreign
exchange, adjusted earnings per share in the range of
Q4 and Fiscal Year Conference Call, Accompanying Slide Presentation and Replay
The Company will host a conference call to review its fourth quarter and
full year results on
Investor Day Scheduled for
In addition, the Company will host an investor day on
Non-GAAP Financial Information
In addition to financial results reported in accordance with generally accepted accounting principles (GAAP), we have provided certain non-GAAP financial information in this release to aid investors in understanding the Company's performance. Each non-GAAP financial measure is defined and reconciled to its most closely related GAAP financial measure in the “About Non-GAAP Financial Measures” section at the end of this earnings release.
About
The Company markets and distributes brand name over-the-counter and
household cleaning products throughout the U.S. and
Note Regarding Forward-Looking Statements
This news release contains "forward-looking statements" within the
meaning of the federal securities laws that are intended to qualify for
the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. "Forward-looking statements" generally
can be identified by the use of forward-looking terminology such as
"outlook," "may," "will," "would," "expect," “intend,” “estimate,”
“anticipate,” “believe,” or "continue" (or the negative or other
derivatives of each of these terms) or similar terminology. The
"forward-looking statements" include, without limitation, statements
regarding our expected future operating results, including revenue
growth, the impact of foreign exchange rates, adjusted EPS, and adjusted
non-GAAP projected free cash flow; our expected use of free cash flow
for deleveraging and building M&A capacity; the integration of the
DenTek acquisition and incremental revenues from it; and our anticipated
organic growth in the legacy business. These statements are based on
management's estimates and assumptions with respect to future events and
financial performance and are believed to be reasonable, though are
inherently uncertain and difficult to predict. Actual results could
differ materially from those expected as a result of a variety of
factors, including the impact of our advertising and promotional
initiatives, general economic and business conditions, regulatory
matters, competition in our industry, supplier issues, the success of
our brand-building investments and integration of newly acquired brands.
A discussion of other factors that could cause results to vary is
included in the Company's Annual Report on Form 10-K for the year ended
Prestige Brands Holdings, Inc.
Consolidated Statements of Income and Comprehensive Income (Unaudited) |
||||||||||||||||||||||
Three Months Ended |
Year Ended March 31, |
|||||||||||||||||||||
(In thousands, except per share data) | 2016 | 2015 | 2016 | 2015 | ||||||||||||||||||
Revenues | ||||||||||||||||||||||
Net sales | $ | 207,054 | $ | 189,089 | $ | 803,088 | $ | 710,070 | ||||||||||||||
Other revenues | 801 | 957 | 3,159 | 4,553 | ||||||||||||||||||
Total revenues |
207,855 | 190,046 | 806,247 | 714,623 | ||||||||||||||||||
Cost of Sales | ||||||||||||||||||||||
Cost of sales (exclusive of depreciation shown below) | 89,604 | 79,976 | 339,036 | 308,400 | ||||||||||||||||||
Gross profit | 118,251 | 110,070 | 467,211 | 406,223 | ||||||||||||||||||
Operating Expenses | ||||||||||||||||||||||
Advertising and promotion | 26,552 | 25,367 | 110,802 | 99,651 | ||||||||||||||||||
General and administrative | 20,232 | 17,685 | 72,418 | 81,273 | ||||||||||||||||||
Depreciation and amortization | 6,198 | 5,773 | 23,676 | 17,740 | ||||||||||||||||||
Total operating expenses | 52,982 | 48,825 | 206,896 | 198,664 | ||||||||||||||||||
Operating income | 65,269 | 61,245 | 260,315 | 207,559 | ||||||||||||||||||
Other (income) expense | ||||||||||||||||||||||
Interest income | (71 | ) | (25 | ) | (162 | ) | (92 | ) | ||||||||||||||
Interest expense | 23,218 | 23,821 | 85,322 | 81,326 | ||||||||||||||||||
Gain on sale of asset | — | — | — | (1,133 | ) | |||||||||||||||||
Loss on extinguishment of debt | 17,519 | — | 17,970 | — | ||||||||||||||||||
Total other expense | 40,666 | 23,796 | 103,130 | 80,101 | ||||||||||||||||||
Income before income taxes | 24,603 | 37,449 | 157,185 | 127,458 | ||||||||||||||||||
Provision for income taxes | 10,667 | 13,677 | 57,278 | 49,198 | ||||||||||||||||||
Net income | $ | 13,936 | $ | 23,772 | $ | 99,907 | $ | 78,260 | ||||||||||||||
Earnings per share: | ||||||||||||||||||||||
Basic | $ | 0.26 | $ | 0.45 | $ | 1.89 | $ | 1.50 | ||||||||||||||
Diluted | $ | 0.26 | $ | 0.45 | $ | 1.88 | $ | 1.49 | ||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||||
Basic | 52,833 | 52,356 | 52,754 | 52,170 | ||||||||||||||||||
Diluted | 53,252 | 52,821 | 53,143 | 52,670 | ||||||||||||||||||
Comprehensive income, net of tax: | ||||||||||||||||||||||
Currency translation adjustments | 6,449 | (7,268 | ) | (113 | ) | (24,151 | ) | |||||||||||||||
Total other comprehensive income (loss) | 6,449 | (7,268 | ) | (113 | ) | (24,151 | ) | |||||||||||||||
Comprehensive income | $ | 20,385 | $ | 16,504 | $ | 99,794 | $ | 54,109 | ||||||||||||||
Prestige Brands Holdings, Inc.
Consolidated Balance Sheets (Unaudited) |
|||||||||||
(In thousands) |
March 31, | ||||||||||
Assets | 2016 | 2015 | |||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 27,230 | $ | 21,318 | |||||||
Accounts receivable, net | 95,247 | 87,858 | |||||||||
Inventories | 91,263 | 74,000 | |||||||||
Deferred income tax assets | 10,108 | 8,097 | |||||||||
Prepaid expenses and other current assets | 25,165 | 10,434 | |||||||||
Total current assets | 249,013 | 201,707 | |||||||||
Property and equipment, net | 15,540 | 13,744 | |||||||||
Goodwill | 360,191 | 290,651 | |||||||||
Intangible assets, net | 2,322,723 | 2,134,700 | |||||||||
Other long-term assets | 1,324 | 1,165 | |||||||||
Total Assets | $ | 2,948,791 | $ | 2,641,967 | |||||||
Liabilities and Stockholders' Equity | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | 38,296 | $ | 46,115 | |||||||
Accrued interest payable | 8,664 | 11,974 | |||||||||
Other accrued liabilities | 59,724 | 40,948 | |||||||||
Total current liabilities | 106,684 | 99,037 | |||||||||
Long-term debt | |||||||||||
Principal amount | 1,652,500 | 1,593,600 | |||||||||
Less unamortized debt costs | (27,191 | ) | (32,327 | ) | |||||||
Long-term debt, net | 1,625,309 | 1,561,273 | |||||||||
Deferred income tax liabilities | 469,622 | 351,569 | |||||||||
Other long-term liabilities | 2,840 | 2,464 | |||||||||
Total Liabilities | 2,204,455 | 2,014,343 | |||||||||
Stockholders' Equity | |||||||||||
Preferred stock - $0.01 par value | |||||||||||
Authorized - 5,000 shares | |||||||||||
Issued and outstanding - None | — | — | |||||||||
Common stock - $0.01 par value | |||||||||||
Authorized - 250,000 shares | |||||||||||
Issued – 53,066 shares at March 31, 2016 and 52,562 shares at March 31, 2015 | 530 | 525 | |||||||||
Additional paid-in capital | 445,182 | 426,584 | |||||||||
Treasury stock, at cost – 306 shares at March 31, 2016 and 266 at March 31, 2015 | (5,163 | ) | (3,478 | ) | |||||||
Accumulated other comprehensive income (loss), net of tax | (23,525 | ) | (23,412 | ) | |||||||
Retained earnings | 327,312 | 227,405 | |||||||||
Total Stockholders' Equity | 744,336 | 627,624 | |||||||||
Total Liabilities and Stockholders' Equity | $ | 2,948,791 | $ | 2,641,967 | |||||||
Prestige Brands Holdings, Inc.
Consolidated Statements of Cash Flows (Unaudited) |
|||||||||||
Year Ended March 31, | |||||||||||
(In thousands) |
2016 | 2015 | |||||||||
Operating Activities | |||||||||||
Net income | $ | 99,907 | $ | 78,260 | |||||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||||||||
Depreciation and amortization | 23,676 | 17,740 | |||||||||
Gain on sale of asset | — | (1,133 | ) | ||||||||
Deferred income taxes | 46,152 | 28,922 | |||||||||
Long term income taxes payable | (332 | ) | 2,294 | ||||||||
Amortization of debt origination costs | 8,994 | 8,821 | |||||||||
Stock-based compensation costs | 9,954 | 6,918 | |||||||||
Loss on extinguishment of debt | 17,970 | — | |||||||||
Premium payment on 2012 Senior Notes | (10,158 | ) | — | ||||||||
Lease termination costs | — | 785 | |||||||||
(Gain) loss on sale or disposal of property and equipment | (35 | ) | 321 | ||||||||
Changes in operating assets and liabilities, net of effects from acquisitions | |||||||||||
Accounts receivable | 1,824 | 1,608 | |||||||||
Inventories | (3,005 | ) | 15,360 | ||||||||
Prepaid expenses and other current assets | (7,921 | ) | 4,664 | ||||||||
Accounts payable | (11,348 | ) | (17,637 | ) | |||||||
Accrued liabilities | (1,328 | ) | 9,332 | ||||||||
Net cash provided by operating activities | 174,350 | 156,255 | |||||||||
Investing Activities | |||||||||||
Purchases of property and equipment | (3,568 | ) | (6,101 | ) | |||||||
Proceeds from the sale of property and equipment | 344 | — | |||||||||
Proceeds from sale of business | — | 18,500 | |||||||||
Proceeds from sale of asset | — | 10,000 | |||||||||
Proceeds from Insight Pharmaceuticals working capital arbitration settlement | 7,237 | — | |||||||||
Acquisition of DenTek, less cash acquired | (226,984 | ) | — | ||||||||
Acquisition of Insight Pharmaceuticals, less cash acquired | — | (749,666 | ) | ||||||||
Acquisition of the Hydralyte brand | — | (77,991 | ) | ||||||||
Net cash used in investing activities | (222,971 | ) | (805,258 | ) | |||||||
Financing Activities | |||||||||||
Proceeds from issuance of 2016 Senior Notes | 350,000 | — | |||||||||
Repayment of 2012 Senior Notes | (250,000 | ) | — | ||||||||
Borrowings under Bridge term loans | 80,000 | — | |||||||||
Repayments under Bridge term loans | (80,000 | ) | — | ||||||||
Term loan borrowings | — | 720,000 | |||||||||
Term loan repayments | (60,000 | ) | (130,000 | ) | |||||||
Borrowings under revolving credit agreement | 115,000 | 124,600 | |||||||||
Repayments under revolving credit agreement | (96,100 | ) | (58,500 | ) | |||||||
Payments of debt origination costs | (11,828 | ) | (16,072 | ) | |||||||
Proceeds from exercise of stock options | 6,689 | 3,954 | |||||||||
Proceeds from restricted stock exercises | 544 | 57 | |||||||||
Excess tax benefits from share-based awards | 1,960 | 1,330 | |||||||||
Fair value of shares surrendered as payment of tax withholding | (2,229 | ) | (2,104 | ) | |||||||
Net cash provided by financing activities | 54,036 | 643,265 | |||||||||
Effects of exchange rate changes on cash and cash equivalents | 497 | (1,275 | ) | ||||||||
Increase (decrease) in cash and cash equivalents | 5,912 | (7,013 | ) | ||||||||
Cash and cash equivalents - beginning of year | 21,318 | 28,331 | |||||||||
Cash and cash equivalents - end of year | $ | 27,230 | $ | 21,318 | |||||||
Interest paid | $ | 79,132 | $ | 70,155 | |||||||
Income taxes paid | $ | 15,352 | $ | 11,939 | |||||||
Prestige Brands Holdings, Inc.
Consolidated Statements of Income
Business Segments (Unaudited) |
|||||||||||||||||||||
|
|||||||||||||||||||||
Three Months Ended March 31, 2016 | |||||||||||||||||||||
(In thousands) |
North |
International |
Household Cleaning |
Consolidated | |||||||||||||||||
Gross segment revenues | $ | 171,294 | $ | 14,416 | $ | 21,577 | $ | 207,287 | |||||||||||||
Elimination of intersegment revenues | (233 | ) | — | — | (233 | ) | |||||||||||||||
Third-party segment revenues | 171,061 | 14,416 | 21,577 | 207,054 | |||||||||||||||||
Other revenues | — | 2 | 799 | 801 | |||||||||||||||||
Total segment revenues | 171,061 | 14,418 | 22,376 | 207,855 | |||||||||||||||||
Cost of sales | 69,873 | 3,195 | 16,536 | 89,604 | |||||||||||||||||
Gross profit | 101,188 | 11,223 | 5,840 | 118,251 | |||||||||||||||||
Advertising and promotion | 23,286 | 2,776 | 490 | 26,552 | |||||||||||||||||
Contribution margin | $ | 77,902 | $ | 8,447 | $ | 5,350 | $ | 91,699 | |||||||||||||
Other operating expenses | 26,430 | ||||||||||||||||||||
Operating income | 65,269 | ||||||||||||||||||||
Other expense | 40,666 | ||||||||||||||||||||
Income before income taxes | 24,603 | ||||||||||||||||||||
Provision for income taxes | 10,667 | ||||||||||||||||||||
Net income | $ | 13,936 | |||||||||||||||||||
Year Ended March 31, 2016 | |||||||||||||||||||||
(In thousands) |
North |
International |
Household |
Consolidated | |||||||||||||||||
Gross segment revenues* | $ | 660,518 | $ | 57,670 | $ | 87,561 | $ | 805,749 | |||||||||||||
Elimination of intersegment revenues | (2,661 | ) | — | — | (2,661 | ) | |||||||||||||||
Third-party segment revenues | 657,857 | 57,670 | 87,561 | 803,088 | |||||||||||||||||
Other revenues* | 14 | 43 | 3,102 | 3,159 | |||||||||||||||||
Total segment revenues | 657,871 | 57,713 | 90,663 | 806,247 | |||||||||||||||||
Cost of sales | 252,152 | 19,542 | 67,342 | 339,036 | |||||||||||||||||
Gross profit | 405,719 | 38,171 | 23,321 | 467,211 | |||||||||||||||||
Advertising and promotion | 97,393 | 11,114 | 2,295 | 110,802 | |||||||||||||||||
Contribution margin | $ | 308,326 | $ | 27,057 | $ | 21,026 | $ | 356,409 | |||||||||||||
Other operating expenses | 96,094 | ||||||||||||||||||||
Operating income | 260,315 | ||||||||||||||||||||
Other expense | 103,130 | ||||||||||||||||||||
Income before income taxes | 157,185 | ||||||||||||||||||||
Provision for income taxes | 57,278 | ||||||||||||||||||||
Net income | $ | 99,907 | |||||||||||||||||||
Three Months Ended March 31, 2015 | |||||||||||||||||||||
(In thousands) |
North |
International |
Household Cleaning |
Consolidated | |||||||||||||||||
Gross segment revenues* | $ | 156,940 | $ | 12,572 | $ | 20,028 | $ | 189,540 | |||||||||||||
Elimination of intersegment revenues | (451 | ) | — | — | (451 | ) | |||||||||||||||
Third-party segment revenues | 156,489 | 12,572 | 20,028 | 189,089 | |||||||||||||||||
Other revenues | 159 | 2 | 796 | 957 | |||||||||||||||||
Total segment revenues | 156,648 | 12,574 | 20,824 | 190,046 | |||||||||||||||||
Cost of sales | 58,776 | 4,894 | 16,306 | 79,976 | |||||||||||||||||
Gross profit | 97,872 | 7,680 | 4,518 | 110,070 | |||||||||||||||||
Advertising and promotion | 22,324 | 2,771 | 272 | 25,367 | |||||||||||||||||
Contribution margin | $ | 75,548 | $ | 4,909 | $ | 4,246 | $ | 84,703 | |||||||||||||
Other operating expenses | 23,458 | ||||||||||||||||||||
Operating income | 61,245 | ||||||||||||||||||||
Other expense | 23,796 | ||||||||||||||||||||
Income before income taxes | 37,449 | ||||||||||||||||||||
Provision for income taxes | 13,677 | ||||||||||||||||||||
Net income | $ | 23,772 | |||||||||||||||||||
Year Ended March 31, 2015 | |||||||||||||||||||||
(In thousands) |
North |
International |
Household |
Consolidated | |||||||||||||||||
Gross segment revenues* | $ | 569,643 | $ | 57,729 | $ | 86,085 | $ | 713,457 | |||||||||||||
Elimination of intersegment revenues | (3,387 | ) | — | — | (3,387 | ) | |||||||||||||||
Third-party segment revenues | 566,256 | 57,729 | 86,085 | 710,070 | |||||||||||||||||
Other revenues | 637 | 64 | 3,852 | 4,553 | |||||||||||||||||
Total segment revenues | 566,893 | 57,793 | 89,937 | 714,623 | |||||||||||||||||
Cost of sales | 216,781 | 22,820 | 68,799 | 308,400 | |||||||||||||||||
Gross profit | 350,112 | 34,973 | 21,138 | 406,223 | |||||||||||||||||
Advertising and promotion | 86,897 | 10,922 | 1,832 | 99,651 | |||||||||||||||||
Contribution margin | $ | 263,215 | $ | 24,051 | $ | 19,306 | $ | 306,572 | |||||||||||||
Other operating expenses | 99,013 | ||||||||||||||||||||
Operating income | 207,559 | ||||||||||||||||||||
Other expense | 80,101 | ||||||||||||||||||||
Income before income taxes | 127,458 | ||||||||||||||||||||
Provision for income taxes | 49,198 | ||||||||||||||||||||
Net income | $ | 78,260 | |||||||||||||||||||
*Certain immaterial amounts relating to intersegment revenues and other
revenues were reclassified between the
About Non-GAAP Financial Measures
We define Non-GAAP Organic Revenues as Total Revenues excluding revenues associated with products acquired or divested in the periods presented. We define Non-GAAP Organic Revenues on a Constant Currency basis as Total Revenues excluding acquisitions and divestitures and the impact of current year foreign exchange rates on total revenues. We define Non-GAAP Total Revenues on a Constant Currency basis as Total Revenues excluding the impact of currency exchange rates on total revenues. We define Non-GAAP Adjusted EBITDA as earnings before interest expense (income), income taxes, depreciation and amortization, inventory step-up charges, certain other legal and professional fees, other acquisition-related costs, costs associated with our CEO transition, gain on sale of asset, and loss on extinguishment of debt. Non-GAAP Adjusted EBITDA Margin is calculated as Non-GAAP Adjusted EBITDA divided by GAAP Total Revenues. We define Non-GAAP Adjusted Gross Margin as Gross Profit before inventory step up charges, and certain other acquisition and integration-related costs. Non-GAAP Adjusted Gross Margin percentage is calculated based on Non-GAAP Adjusted Gross Margin divided by GAAP Total Revenues. We define Non-GAAP Adjusted General and Administrative expenses as General and Administrative expenses minus certain other legal and professional fees, acquisition and other integration costs, and costs associated with our CEO transition. Non-GAAP Adjusted General and Administrative expense percentage is calculated based on Non-GAAP Adjusted General and Administrative expense divided by GAAP Total Revenues. We define Non-GAAP Adjusted Net Income as Net Income before inventory step-up charges, certain other legal and professional fees, other acquisition and integration-related costs, costs associated with our CEO transition, accelerated amortization of debt origination costs, gain on sale of asset, loss on extinguishment of debt, and the applicable tax impacts associated with these items and other non-deductible items. Non-GAAP Adjusted EPS is calculated based on Non-GAAP Adjusted Net Income, divided by the weighted average number of common and potential common shares outstanding during the period. We define Non-GAAP Free Cash Flow as net cash provided by operating activities less cash paid for capital expenditures. We define Non-GAAP Adjusted Free Cash Flow as net cash provided by operating activities less purchases of property and equipment plus payments associated with a premium on extinguishment of the 2012 Senior Notes and acquisitions for integration, transition, and other payments associated with acquisitions. Non-GAAP Organic Revenues, Non-GAAP Organic Revenues on a Constant Currency basis, Non-GAAP Total Revenues on a Constant Currency basis, Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted EBITDA Margin, Non-GAAP Adjusted Gross Margin, Non-GAAP Adjusted Gross Margin percentage, Non-GAAP Adjusted General and Administrative Expense, Non-GAAP Adjusted General and Administrative Expense percentage, Non-GAAP Adjusted Net Income, Non-GAAP Adjusted EPS, Non-GAAP Free Cash Flow, and Non-GAAP Adjusted Free Cash Flow may not be comparable to similarly titled measures reported by other companies.
We are presenting Non-GAAP Organic Revenues, Non-GAAP Organic Revenues on a Constant Currency basis, Non-GAAP Total Revenues on a Constant Currency basis, Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted EBITDA Margin, Non-GAAP Adjusted Gross Margin, Non-GAAP Adjusted Gross Margin percentage, Non-GAAP Adjusted General and Administrative Expense, Non-GAAP Adjusted General and Administrative Expense percentage, Non-GAAP Adjusted Net Income, Non-GAAP Adjusted EPS, Non-GAAP Free Cash Flow, and Non-GAAP Adjusted Free Cash Flow, because they provide additional ways to view our operation when considered with both our GAAP results and the reconciliation to net income and net cash provided by operating activities, respectively, which we believe provides a more complete understanding of our business than could be obtained absent this disclosure. Each of Non-GAAP Organic Revenues, Non-GAAP Organic Revenues on a Constant Currency basis, Non-GAAP Total Revenues on a Constant Currency basis, Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted EBITDA Margin, Non-GAAP Adjusted Gross Margin, Non-GAAP Adjusted Gross Margin percentage, Non-GAAP Adjusted General and Administrative Expense, Non-GAAP Adjusted General and Administrative Expense percentage, Non-GAAP Adjusted Net Income, Non-GAAP Adjusted EPS, Non-GAAP Free Cash Flow, and Non-GAAP Adjusted Free Cash Flow is presented solely as a supplemental disclosure because (i) we believe it is a useful tool for investors to assess the operating performance of the business without the effect of these items; (ii) we believe that investors will find this data useful in assessing shareholder value; and (iii) we use Non-GAAP Organic Revenues, Non-GAAP Organic Revenues on a Constant Currency basis, Non-GAAP Total Revenues on a Constant Currency basis, Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted EBITDA Margin, Non-GAAP Adjusted Gross Margin, Non-GAAP Adjusted Gross Margin percentage, Non-GAAP Adjusted General and Administrative Expense, Non-GAAP Adjusted General and Administrative Expense percentage, Non-GAAP Adjusted Net Income, Non-GAAP Adjusted EPS, Non-GAAP Free Cash Flow, and Non-GAAP Adjusted Free Cash Flow internally to evaluate the performance of our personnel and also as a benchmark to evaluate our operating performance or compare our performance to that of our competitors. The use of Non-GAAP Organic Revenues, Non-GAAP Organic Revenues on a Constant Currency basis, Non-GAAP Total Revenues on a Constant Currency basis, Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted EBITDA Margin, Non-GAAP Adjusted Gross Margin, Non-GAAP Adjusted Gross Margin percentage, Non-GAAP Adjusted General and Administrative Expense, Non-GAAP Adjusted General and Administrative Expense percentage, Non-GAAP Adjusted Net Income, Non-GAAP Adjusted EPS, Non-GAAP Free Cash Flow, and Non-GAAP Adjusted Free Cash Flow have limitations, and you should not consider these measures in isolation from or as an alternative to GAAP measures such as Total Revenues, General and Administrative expense, Operating income, Net income, and Net cash flow provided by operating activities, or cash flow statement data prepared in accordance with GAAP, or as a measure of profitability or liquidity.
The following tables set forth the reconciliation of Non-GAAP Organic Revenues, Non-GAAP Organic Revenues on a Constant Currency basis, Non-GAAP Total Revenues on a Constant Currency basis, Non-GAAP Adjusted EBITDA, Non-GAAP Adjusted EBITDA Margin, Non-GAAP Adjusted Gross Margin, Non-GAAP Adjusted Gross Margin percentage, Non-GAAP Adjusted General and Administrative Expense, Non-GAAP Adjusted General and Administrative Expense percentage, Non-GAAP Adjusted Net Income, Non-GAAP Adjusted EPS, Non-GAAP Free Cash Flow, and Non-GAAP Adjusted Free Cash Flow, all of which are non-GAAP financial measures, to GAAP Gross Profit, GAAP General and Administrative expense, GAAP Net Income, GAAP Diluted EPS and GAAP Net cash provided by operating activities, our most directly comparable financial measures presented in accordance with GAAP.
Reconciliation of GAAP Total Revenues to Non-GAAP Organic Revenues and Non-GAAP Organic Revenues on a Constant Currency basis and related growth percentages:
Three Months Ended |
Year Ended March 31, |
|||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||
(In thousands) |
||||||||||||||||||||||
GAAP Total Revenues | $ | 207,855 | $ | 190,046 | $ | 806,247 | $ | 714,623 | ||||||||||||||
Adjustments: |
||||||||||||||||||||||
Hydralyte revenues (1) | — | — | (1,217 | ) | — | |||||||||||||||||
Insight revenues (2) | — | — | (73,630 | ) | — | |||||||||||||||||
DenTek revenues (3) | (10,687 | ) | — | (10,687 | ) | — | ||||||||||||||||
Total adjustments | (10,687 | ) | — | (85,534 | ) | — | ||||||||||||||||
Non-GAAP Organic Revenues | 197,168 | 190,046 | 720,713 | 714,623 | ||||||||||||||||||
Organic Revenue Growth (Decline) | 3.7 | % | 0.9 | % | ||||||||||||||||||
Impact of foreign currency exchange rates (4) | (2,257 | ) | (13,862 | ) | ||||||||||||||||||
Non-GAAP Organic Revenues on a constant currency basis | $ | 197,168 | $ | 187,789 | $ | 720,713 | $ | 700,761 | ||||||||||||||
Constant Currency Organic Revenue Growth | 5.0 | % | 2.8 | % | ||||||||||||||||||
(1) | Revenue adjustments relate to our International OTC Healthcare segment | |
(2) | Revenue adjustments relate to our North American OTC Healthcare segment | |
(3) | Revenue adjustments relate to our North American and International OTC Healthcare segment | |
(4) | Foreign currency exchange rate adjustments relate to all segments | |
Reconciliation of GAAP Total Revenues to Non-GAAP Total Revenues on a Constant Currency basis and related growth percentages:
Three Months Ended |
Year Ended March 31, |
|||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||
(In thousands) |
||||||||||||||||||||||
GAAP Total Revenues | $ | 207,855 | $ | 190,046 | $ | 806,247 | $ | 714,623 | ||||||||||||||
Impact of foreign currency exchange rates (1) | — | (2,257 | ) | — | (13,862 | ) | ||||||||||||||||
Non-GAAP Total Revenues on a constant currency basis | $ | 207,855 | $ | 187,789 | $ | 806,247 | $ | 700,761 | ||||||||||||||
Constant Currency Revenue Growth | 10.7 | % | 15.1 | % | ||||||||||||||||||
(1) | Foreign currency exchange rate adjustments relate to all segments | |
Reconciliation of GAAP Gross Profit to Non-GAAP Adjusted Gross Margin and related Adjusted Gross Margin percentage:
Three Months Ended |
Year Ended |
|||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||
(In thousands) |
||||||||||||||||||||||
GAAP Total Revenues | $ | 207,855 | $ | 190,046 | $ | 806,247 | $ | 714,623 | ||||||||||||||
GAAP Gross Profit | $ | 118,251 | $ | 110,070 | $ | 467,211 | $ | 406,223 | ||||||||||||||
Adjustments: |
||||||||||||||||||||||
Inventory step-up charges and other costs associated with the Hydralyte acquisition (1) | — | — | — | 246 | ||||||||||||||||||
Inventory step-up charges associated with Insight acquisition (2) | — | — | — | 1,979 | ||||||||||||||||||
Inventory step-up charges and other costs associated with the DenTek acquisition (3) | 1,387 | — | 1,387 | — | ||||||||||||||||||
Total adjustments | 1,387 | — | 1,387 | 2,225 | ||||||||||||||||||
Non-GAAP Adjusted Gross Margin | $ | 119,638 | $ | 110,070 | $ | 468,598 | $ | 408,448 | ||||||||||||||
Non-GAAP Adjusted Gross Margin % | 57.6 | % | 57.9 | % | 58.1 | % | 57.2 | % | ||||||||||||||
(1) | Inventory step-up charges and other costs relate to our International OTC Healthcare segment | |
(2) | Inventory step-up charges relate to our North American OTC Healthcare segment | |
(3) | Inventory step-up charges relate to our North American and International OTC Healthcare segments | |
Reconciliation of GAAP General and Administrative Expense to Non-GAAP Adjusted General and Administrative Expense and related Non-GAAP Adjusted General and Administrative Expense percentage:
Three Months Ended |
Year Ended |
|||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||
(In thousands) |
||||||||||||||||||||||
GAAP General and Administrative Expense | $ | 20,232 | $ | 17,685 | $ | 72,418 | $ | 81,273 | ||||||||||||||
Adjustments: |
||||||||||||||||||||||
Costs associated with CEO transition | — | — | 1,406 | — | ||||||||||||||||||
Legal and professional fees associated with acquisitions | 1,096 | 640 | 2,112 | 10,974 | ||||||||||||||||||
Stamp/Duty Tax on Australian acquisition | — | — | — | 2,940 | ||||||||||||||||||
Integration, transition and other costs associated with acquisitions | 289 | 920 | 289 | 10,533 | ||||||||||||||||||
Total adjustments | 1,385 | 1,560 | 3,807 | 24,447 | ||||||||||||||||||
Non-GAAP Adjusted General and Administrative Expense | $ | 18,847 | $ | 16,125 | $ | 68,611 | $ | 56,826 | ||||||||||||||
Non-GAAP Adjusted General and Administrative Expense Percentage | 9.1 | % | 8.5 | % | 8.5 | % | 8.0 | % | ||||||||||||||
Reconciliation of GAAP Net Income to Non-GAAP Adjusted EBITDA and related Non-GAAP Adjusted EBITDA Margin:
Three Months Ended |
Year Ended |
|||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||
(In thousands) |
||||||||||||||||||||||
GAAP Net Income | $ | 13,936 | $ | 23,772 | $ | 99,907 | $ | 78,260 | ||||||||||||||
Interest expense, net | 23,147 | 23,796 | 85,160 | 81,234 | ||||||||||||||||||
Provision for income taxes | 10,667 | 13,677 | 57,278 | 49,198 | ||||||||||||||||||
Depreciation and amortization | 6,198 | 5,773 | 23,676 | 17,740 | ||||||||||||||||||
Non-GAAP EBITDA: | 53,948 | 67,018 | 266,021 | 226,432 | ||||||||||||||||||
Adjustments: |
||||||||||||||||||||||
Inventory step-up charges and other costs associated with the Hydralyte acquisition (1) | — | — | — | 246 | ||||||||||||||||||
Inventory step-up charges associated with Insight acquisition (2) | — | — | — | 1,979 | ||||||||||||||||||
Inventory step-up charges and other costs associated with the DenTek acquisition (3) | 1,387 | — | 1,387 | — | ||||||||||||||||||
Costs associated with CEO transition (4) | — | — | 1,406 | — | ||||||||||||||||||
Legal and professional fees associated with acquisitions (4) | 1,096 | 640 | 2,112 | 10,974 | ||||||||||||||||||
Stamp/Duty Tax on Australian acquisition (4) | — | — | — | 2,940 | ||||||||||||||||||
Integration, transition and other costs associated with acquisitions (4) | 289 | 920 | 289 | 10,533 | ||||||||||||||||||
Gain on sale of asset | — | — | — | (1,133 | ) | |||||||||||||||||
Loss on extinguishment of debt | 17,519 | — | 17,970 | — | ||||||||||||||||||
Total adjustments | 20,291 | 1,560 | 23,164 | 25,539 | ||||||||||||||||||
Non-GAAP Adjusted EBITDA | $ | 74,239 | $ | 68,578 | $ | 289,185 | $ | 251,971 | ||||||||||||||
Non-GAAP Adjusted EBITDA Margin | 35.7 | % | 36.1 | % | 35.9 | % | 35.3 | % | ||||||||||||||
(1) | Inventory step-up charges and other costs relate to our International OTC Healthcare segment | |
(2) | Inventory step-up charges relate to our North American OTC Healthcare segment | |
(3) | Inventory step-up charges relate to our North American and International OTC Healthcare segments | |
(4) | Adjustments relate to G&A expenses | |
Reconciliation of GAAP Net Income to Non-GAAP Adjusted Net Income and related Adjusted Earnings Per Share:
Three Months Ended March 31, | Year Ended March 31, | |||||||||||||||||||||||||||||||||||||
2016 |
2016 |
2015 |
2015 |
2016 |
2016 |
2015 |
2015 |
|||||||||||||||||||||||||||||||
(In thousands) |
||||||||||||||||||||||||||||||||||||||
GAAP Net Income | $ | 13,936 | $ | 0.26 | $ | 23,772 | $ | 0.45 | $ | 99,907 | $ | 1.88 | $ | 78,260 | $ | 1.49 | ||||||||||||||||||||||
Adjustments: |
||||||||||||||||||||||||||||||||||||||
Inventory step-up charges and other costs associated the Hydralyte acquisition (1) | — | — | — | — | — | — | 246 | — | ||||||||||||||||||||||||||||||
Inventory step-up charges associated with Insight acquisition (2) | — | — | — | — | — | — | 1,979 | 0.04 | ||||||||||||||||||||||||||||||
Inventory step-up charges and other costs associated with the DenTek acquisition (3) | 1,387 | 0.03 | — | — | 1,387 | 0.03 | — | — | ||||||||||||||||||||||||||||||
Costs associated with CEO transition (4) | — | — | — | — | 1,406 | 0.02 | — | — | ||||||||||||||||||||||||||||||
Legal and professional fees associated with acquisitions (4) | 1,096 | 0.02 | 640 | 0.01 | 2,112 | 0.04 | 10,974 | 0.21 | ||||||||||||||||||||||||||||||
Stamp/Duty Tax on Australian acquisition(4) | — | — | — | — | — | — | 2,940 | 0.05 | ||||||||||||||||||||||||||||||
Integration, transition and other costs associated with acquisitions (4) | 289 | 0.01 | 920 | 0.02 | 289 | 0.01 | 10,533 | 0.20 | ||||||||||||||||||||||||||||||
Accelerated amortization of debt origination costs | — | — | — | — | — | — | 218 | — | ||||||||||||||||||||||||||||||
Gain on sale of asset | — | — | — | — | — | — | (1,133 | ) | (0.02 | ) | ||||||||||||||||||||||||||||
Loss on extinguishment of debt | 17,519 | 0.33 | — | — | 17,970 | 0.34 | — | — | ||||||||||||||||||||||||||||||
Tax impact of adjustments | (6,294 | ) | (0.13 | ) | (549 | ) | (0.01 | ) | (7,608 | ) | (0.15 | ) | (5,968 | ) | (0.11 | ) | ||||||||||||||||||||||
Total adjustments | 13,997 | 0.26 | 1,011 | 0.02 | 15,556 | 0.29 | 19,789 | 0.37 | ||||||||||||||||||||||||||||||
Non-GAAP Adjusted Net Income and Adjusted EPS | $ | 27,933 | $ | 0.52 | $ | 24,783 | $ | 0.47 | $ | 115,463 | $ | 2.17 | $ | 98,049 | $ | 1.86 | ||||||||||||||||||||||
(1) | Inventory step-up charges and other costs relate to our International OTC Healthcare segment | |
(2) | Inventory step-up charges relate to our North American OTC Healthcare segment | |
(3) | Inventory step-up charges relate to our North American and International OTC Healthcare segments | |
(4) | Adjustments relate to G&A expenses | |
Reconciliation of GAAP Net Income to Non-GAAP Free Cash Flow and Non-GAAP Adjusted Free Cash Flow:
Three Months Ended |
Year Ended March 31, |
|||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||
(In thousands) |
||||||||||||||||||||||
GAAP Net Income | $ | 13,936 | $ | 23,772 | $ | 99,907 | $ | 78,260 | ||||||||||||||
Adjustments: |
||||||||||||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities as shown in the Statement of Cash Flows |
34,206 | 22,048 | 96,221 | 64,668 | ||||||||||||||||||
Changes in operating assets and liabilities, net of effects from acquisitions as shown in the Statement of Cash Flows |
(10,243 | ) | 6,293 | (21,778 | ) | 13,327 | ||||||||||||||||
Total adjustments | 23,963 | 28,341 | 74,443 | 77,995 | ||||||||||||||||||
GAAP Net cash provided by operating activities | 37,899 | 52,113 | 174,350 | 156,255 | ||||||||||||||||||
Purchases of property and equipment | (1,028 | ) | (2,401 | ) | (3,568 | ) | (6,101 | ) | ||||||||||||||
Non-GAAP Free Cash Flow | 36,871 | 49,712 | 170,782 | 150,154 | ||||||||||||||||||
Premium payment on extinguishment of 2012 Senior Notes | 10,158 | — | 10,158 | — | ||||||||||||||||||
Integration, transition and other payments associated with acquisitions | 1,665 | 362 | 2,461 | 13,563 | ||||||||||||||||||
Adjusted Non-GAAP Free Cash Flow | $ | 48,694 | $ | 50,074 | $ | 183,401 | $ | 163,717 | ||||||||||||||
Outlook for Fiscal Year 2017:
Reconciliation of Projected GAAP EPS to Projected Non-GAAP Adjusted EPS:
2017 Projected EPS | ||||||||||
Low | High | |||||||||
Projected FY'17 GAAP EPS | $ | 2.22 | $ | 2.28 | ||||||
Adjustments: | ||||||||||
Costs associated with DenTek integration | 0.08 | 0.08 | ||||||||
Total adjustments | 0.08 | 0.08 | ||||||||
Projected Non-GAAP Adjusted EPS | $ | 2.30 | $ | 2.36 | ||||||
Reconciliation of Projected GAAP Net cash provided by operating activities to Projected Non-GAAP Free Cash Flow:
2017 |
||||||
(In millions) |
||||||
Projected FY'17 GAAP Net cash provided by operating activities | $ | 190 | ||||
Additions to property and equipment for cash | (8 | ) | ||||
Projected Non-GAAP Free Cash Flow | 182 | |||||
Payments associated with acquisitions | 3 | |||||
Adjusted Non-GAAP Projected Free Cash Flow | $ | 185 | ||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20160512005216/en/
Source:
Prestige Brands Holdings, Inc.
Dean Siegal, 914-524-6819
or
John
Mills, 646-277-1254